Search results

1558 results

Sorted by Relevance . Sort by Date

  1. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

  2. Postnatal care

    In development [GID-NG10070] Expected publication date: TBC

  3. Antenatal care

    In development [GID-NG10096] Expected publication date: 21 April 2021

  4. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: TBC

  5. Shared decision making

    In development [GID-NG10120] Expected publication date: TBC

  6. Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (TA242)

    Evidence-based recommendations on cetuximab (Erbitux), bevacizumab (Avastin) and panitumumab (Vectibix) for treating metastatic colorectal cancer..

  7. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (TA243)

    Evidence-based recommendations on rituximab (MabThera) for the first-line treatment of stage III–IV follicular lymphoma

  8. Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)

    Evidence-based recommendations on rivaroxaban (Xarelto) for preventing stroke and systemic embolism in atrial fibrillation (AF)